Physitrack Group
Investor Relations

Shaping the future of digital health by building value for key stakeholders through innovation and sustainable business management.

Loading last update time…

Recent reports and webcasts

Interim Report Q3

1st of July - 30th September 2025

From 2024 Annual Report

Key financial highlights

14
%

Year-on-year organic growth


1600
K

Total available liquidity

30
%

Operating cash flow (MSEK)

Physitrack Spotlight

Gain exclusive access to comprehensive insights that transcend conventional press releases through our Spotlight newsroom.